Gilead Sciences (GILD) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 41.5% | 32.4% | 38.7% | 15.4% | 46.1% | 44.8% | ||
| Changes by years, y/y, % | +25pp | -9pp | +6pp | -23pp | +31pp | +22.5% | |||
Gilead Sciences. EBITDA margin, %
Gilead Sciences. EBITDA margin, changes, pp
Gilead Sciences (GILD) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 39.1% | 47.6% | 59.0% | 38.1% | 33.8% | 44.8% | |
| Changes by years, y/y, % | +92pp | +5pp | +34pp | -3pp | -5pp | |||
| Changes by quarters, q/q, % | -2pp | +9pp | +11pp | -21pp | -4pp | |||